Hvsen
300871.SZHvsen Biotechnology Co., Ltd. Price (300871.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
165,982,423
(0.333)%Revenue and Profitability
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 257,783,400 | 399,715,931 | 421,874,231 | 427,217,126 | 777,458,548 | 996,216,817 | 1,022,900,792 | 1,019,758,798 |
| Net Income | 49,423,100 | 88,424,284 | 71,401,573 | 68,766,353 | 150,156,108 | 132,865,534 | 52,706,475 | 16,780,818 |
| FCF USD | 32,034,500 | 24,158,842 | -12,958,824 | -17,817,757 | -182,494,689 | -444,404,031 | -332,184,852 | -91,392,492 |
| OCF USD | 60,004,000 | 80,558,562 | 21,095,638 | 105,241,482 | 48,349,261 | 155,718,489 | 96,680,490 | 92,919,343 |
Financial Health - DEBT
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.01 | 0.01 | 0.49 | 0.00 | 4.32 | 10.82 | 35.85 |
| D/E | 0.01 | 0.00 | 0.08 | 0.20 | 0.05 | 0.42 | 0.51 | 0.56 |
| CA/CL | 1.39 | 1.50 | 1.98 | 1.44 | 3.48 | 3.18 | 1.68 | 1.62 |
| TA/TL | 2.53 | 2.84 | 3.28 | 2.39 | 4.70 | 2.44 | 2.06 | 2.03 |
| Total Debt | 1,000,000 | 1,000,000 | 25,000,000 | 75,576,427 | 72,702,070 | 680,981,213 | 790,445,062 | 842,243,683 |
Management Performance
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| ROIC | 29.32% | 38.97% | 20.20% | 14.46% | 10.20% | 5.66% | 2.29% | 0.84% |
| ROE | 31.95% | 39.63% | 22.00% | 18.18% | 10.89% | 8.21% | 3.42% | 1.11% |
| ROA | 0.00% | 25.69% | 15.30% | 10.58% | 8.57% | 4.85% | 1.76% | 0.56% |
| NM % | 19.17% | 22.12% | 16.92% | 16.10% | 19.31% | 13.34% | 5.15% | 1.65% |
| FCF / R% | 0.00% | 6.04% | -3.07% | -4.17% | -23.47% | -44.61% | -32.47% | -8.96% |
| FCF / NI% | 64.85% | 27.33% | -18.15% | -25.91% | -121.54% | -334.48% | -630.25% | -544.62% |
| Operating Margin (OM) | 0.00 | 0.19 | 0.29 | 0.40 | 0.40 | 0.38 | 0.37 | 0.34 |
Per Share
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EPS | 0.30 | 0.74 | 0.59 | 0.41 | 0.91 | 0.80 | 0.32 | 0.10 |
| SPS | 1.56 | 3.35 | 3.51 | 2.58 | 4.69 | 6.00 | 6.18 | 6.14 |
| OCPS | 0.36 | 0.67 | 0.18 | 0.63 | 0.29 | 0.94 | 0.58 | 0.56 |
| FCPS | 0.19 | 0.20 | -0.11 | -0.11 | -1.10 | -2.68 | -2.01 | -0.55 |
| BVPS | 0.93 | 1.87 | 2.70 | 2.28 | 8.32 | 9.75 | 9.32 | 9.09 |
Per Share - CAGR
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.30 | 0.74 | 0.59 | 0.41 | 0.91 | 0.80 | 0.32 | 0.10 |
| CAGR-SPS | 1.56 | 3.35 | 3.51 | 2.58 | 4.69 | 6.00 | 6.18 | 6.14 |
| CAGR-OCPS | 0.36 | 0.67 | 0.18 | 0.63 | 0.29 | 0.94 | 0.58 | 0.56 |
| CAGR-FCPS | 0.19 | 0.20 | -0.11 | -0.11 | -1.10 | -2.68 | -2.01 | -0.55 |
| CAGR-BVPS | 0.93 | 1.87 | 2.70 | 2.28 | 8.32 | 9.75 | 9.32 | 9.09 |